Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Scinai Immunotherapeutics Ltd ADR (SCNI)

Scinai Immunotherapeutics Ltd ADR (SCNI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Scinai Immunotherapeutics Ltd ADR JERUSALEM BIOPARK 2ND FLOOR HADASSAH EIN KEREM CAMPUS JERUSALEM L3 00000 ISR

www.scinai.com P: 972-8930-2529 F: 972-893-0253

Description:

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing inflammation and immunology biological products primarily for the treatment of autoimmune and infectious diseases. Scinai Immunotherapeutics Ltd., formerly known as BiondVax Pharmaceuticals Ltd., is based in JERUSALEM.

Key Statistics

Overview:

Market Capitalization, $K 2,038
Enterprise Value, $K 16,398
Shares Outstanding, K 464
Annual Sales, $ 0 K
Annual Net Income, $ -6,500 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,160 K
EBIT, $ -6,530 K
EBITDA, $ -9,200 K
60-Month Beta 2.50
% of Insider Shareholders 60.90%
% of Institutional Shareholders 58.41%
Float, K 182
% Float 39.10%
Short Volume Ratio 0.45

Growth:

1-Year Return -68.85%
3-Year Return -98.47%
5-Year Return -99.32%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 53.78%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -4.00 on 07/02/24
Next Earnings Date 08/09/24
Earnings Per Share ttm -261.70
EPS Growth vs. Prev Qtr 98.33%
EPS Growth vs. Prev Year 66.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 05/21/24

SCNI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -107.93%
Profit Margin % 0.00%
Debt/Equity -4.24
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -9.93
Interest Coverage -0.44
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar